Prot #M13-365: A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination with Rituximab in Subjects with Relapsed Chronic Lymphocytic Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date6/29/122/25/21

Funding

  • Abbott Laboratories (M13-365)